Coherus BioSciences, Inc. (CHRS)
USD 1.57
(-8.19%)
USD 1.57
(-8.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -174.88 Million | -241.12 Million | -37.43 Million | 154.14 Million | 28.35 Million | -159.26 Million |
| Net Income | -237.89 Million | -291.75 Million | -287.1 Million | 132.24 Million | 89.83 Million | -209.4 Million |
| Depreciation & Amortization | 3.79 Million | 3.69 Million | 3.45 Million | 2.88 Million | 3.25 Million | 3.23 Million |
| Deferred income taxes | 30.47 Million | - | 9.43 Million | -155 Thousand | -55 Thousand | 3.56 Million |
| Stock-based compensation | 43.11 Million | 50.73 Million | 51.36 Million | 38.16 Million | 33.59 Million | 34.79 Million |
| Change in working capital | -36.82 Million | -79.25 Million | 42.36 Million | -32.48 Million | -113.92 Million | 10.29 Million |
| Other non-cash items | 22.45 Million | 75.45 Million | 143.05 Million | 5.98 Million | 15.65 Million | -1.74 Million |
| Investing Cash Flow | 144.64 Million | -166.85 Million | -138.41 Million | -14.4 Million | -12.73 Million | -1.18 Million |
| Investments in PPE | -286 Thousand | -2.03 Million | -1.28 Million | -7.05 Million | -12.89 Million | -789 Thousand |
| Acquisitions | 845 Thousand | - | 1.28 Million | 175 Thousand | 1.65 Million | -700 Thousand |
| Investment purchases | -19.5 Million | -127.38 Million | -182.48 Million | -273.84 Million | -20.23 Million | -42.86 Million |
| Sales/Maturities of investments | 157.64 Million | - | 181.36 Million | 274 Million | 20.4 Million | 43.17 Million |
| Other Investing Activities | 5.94 Million | -37.42 Million | -137.28 Million | -7.67 Million | -1.65 Million | 301 Thousand |
| Financing Cash Flow | 69.6 Million | 54.32 Million | 51.87 Million | 223.94 Million | 89.37 Million | 105.42 Million |
| Debt repayment | - | -190.75 Million | -672 Thousand | -1.26 Million | -72.95 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3.58 Million | -3.74 Million | -1.75 Million | -880 Thousand | -815 Thousand | - |
| Common Stock Issuance | 74.22 Million | 6.35 Million | 40.9 Million | 21.22 Million | 8.15 Million | 101.74 Million |
| Other Financing Activities | -4.62 Million | 246.2 Million | 15.15 Million | 225.21 Million | 227.12 Million | 3.67 Million |
| Accounts receivables | -150.68 Million | 13.05 Million | 34.06 Million | -15.21 Million | -141.99 Million | 8.27 Million |
| Accounts payables | 23.76 Million | -4.54 Million | 874 Thousand | -9.82 Million | 9.89 Million | -534 Thousand |
| Inventory | -46.73 Million | -47.34 Million | -6.25 Million | -36.18 Million | -48.18 Million | -5.48 Million |
| Other working capital | 136.83 Million | -40.41 Million | 13.67 Million | 28.74 Million | 66.35 Million | 8.03 Million |
| Cash at beginning of period | 63.54 Million | 417.63 Million | 541.59 Million | 177.9 Million | 73.19 Million | 127.75 Million |
| Cash at end of period | 102.89 Million | 63.98 Million | 417.63 Million | 541.59 Million | 177.9 Million | 73.19 Million |
| Capital Expenditure | -286 Thousand | -2.03 Million | -1.28 Million | -7.05 Million | -12.89 Million | -789 Thousand |
| Effect of forex changes on cash | 440 Thousand | - | - | - | -276 Thousand | 468 Thousand |
| Net cash flow / Change in cash | 39.34 Million | -353.64 Million | -123.96 Million | 363.69 Million | 104.71 Million | -54.56 Million |
| Free Cash Flow | -175.17 Million | -243.16 Million | -38.72 Million | 147.08 Million | 15.45 Million | -160.05 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.92 Million | 102.87 Million | -79.65 Million | -237.89 Million | -39.64 Million | -42.86 Million |
| Depreciation & Amortization | 1.18 Million | 1.5 Million | 1.06 Million | 3.79 Million | 899 Thousand | 880 Thousand |
| Deferred income taxes | - | - | -69.55 Million | 30.47 Million | 874 Thousand | -1.24 Million |
| Stock-based compensation | 7.23 Million | 7.31 Million | 10.79 Million | 43.11 Million | 9.95 Million | 10.07 Million |
| Change in working capital | 74.26 Million | -11.37 Million | 6.36 Million | -36.82 Million | -27.62 Million | -6.22 Million |
| Other non-cash items | -109.41 Million | -134.49 Million | 118.04 Million | 22.45 Million | 1.23 Million | 468 Thousand |
| Investing Cash Flow | 27.65 Million | 202.76 Million | 35.2 Million | 144.64 Million | 50.54 Million | 41.36 Million |
| Investments in PPE | - | - | -34 Thousand | -286 Thousand | - | -100 Thousand |
| Acquisitions | 227.82 Million | - | 76 Thousand | 845 Thousand | 151 Thousand | 440 Thousand |
| Investment purchases | - | - | 178 Thousand | -19.5 Million | - | -19.5 Million |
| Sales/Maturities of investments | 227.82 Million | 14.88 Million | 36.21 Million | 157.64 Million | 43.39 Million | 60.53 Million |
| Other Investing Activities | -200.16 Million | 187.87 Million | -1.05 Million | 5.94 Million | 6.99 Million | 41.46 Million |
| Financing Cash Flow | -187.92 Million | 887 Thousand | 366 Thousand | 69.6 Million | 11.1 Million | 54.32 Million |
| Debt repayment | -186.77 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.71 Million | -745 Thousand | -326 Thousand | -3.58 Million | -175 Thousand | -305 Thousand |
| Common Stock Issuance | 633 Thousand | 1.79 Million | 891 Thousand | 74.22 Million | 11.43 Million | 53.55 Million |
| Other Financing Activities | -1.78 Million | -911 Thousand | -525 Thousand | -4.62 Million | -157 Thousand | 1.07 Million |
| Accounts receivables | 76.63 Million | 8.57 Million | -44.05 Million | -150.68 Million | -75.27 Million | -39.87 Million |
| Accounts payables | 39.46 Million | 616 Thousand | -785 Thousand | 23.76 Million | 6.75 Million | 6.04 Million |
| Inventory | -7.1 Million | -11.45 Million | -11.79 Million | -46.73 Million | -19.22 Million | -13.04 Million |
| Other working capital | -34.73 Million | -9.11 Million | 63 Million | 136.83 Million | 60.12 Million | 40.64 Million |
| Cash at beginning of period | 259.77 Million | 102.89 Million | 80.71 Million | 63.54 Million | 73.36 Million | 16.58 Million |
| Cash at end of period | 159.24 Million | 259.77 Million | 102.89 Million | 102.89 Million | 80.71 Million | 73.36 Million |
| Capital Expenditure | - | - | -34 Thousand | -286 Thousand | - | -100 Thousand |
| Effect of forex changes on cash | - | - | -452 Thousand | 440 Thousand | 2.6 Million | - |
| Net cash flow / Change in cash | -100.53 Million | 156.88 Million | 22.18 Million | 39.34 Million | 7.35 Million | 56.77 Million |
| Free Cash Flow | 59.73 Million | -46.76 Million | -12.97 Million | -175.17 Million | -54.3 Million | -39.01 Million |
8016
5520
ACEJF
SBET
AMAN
6599